Pictet Asset Management (UK)’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $18.9M | Buy |
102,195
+1,784
| +2% | +$329K | 0.02% | 533 |
|
|
2021
Q1 | $24.7M | Sell |
100,411
-817
| -0.8% | -$201K | 0.03% | 460 |
|
|
2020
Q4 | $28.5M | Sell |
101,228
-1,836
| -2% | -$518K | 0.04% | 414 |
|
|
2020
Q3 | $24.7M | Buy |
103,064
+18,522
| +22% | +$4.45M | 0.04% | 393 |
|
|
2020
Q2 | $28.1M | Buy |
84,542
+53,482
| +172% | +$17.8M | 0.05% | 339 |
|
|
2020
Q1 | $7.07M | Buy |
+31,060
| New | +$7.07M | 0.02% | 548 |
|